Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.410, 2003-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
HIV-1 contacting and testing policy cuts PEP prescribing, costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 366, 2002-01 ,pp. :
Prescribing cuts on the cards in France
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 476, 2005-01 ,pp. :
SSRI and venlafaxine prescribing decreasing in UK paeds
Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. :
SSRI and venlafaxine prescribing decreasing in UK paediatrics
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 494, 2006-01 ,pp. :
Rivastigmine slows AD and cuts costs
Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. :